| Oct 18 |
Tyra raised to buy by BofA ahead of TYRA-300 data readout
|
| Oct 18 |
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
|
| Oct 16 |
Boxer Capital, LLC Increases Stake in Tyra Biosciences Inc
|
| Oct 11 |
Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)
|
| Sep 11 |
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
|
| Sep 10 |
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
|
| Sep 9 |
Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet
|
| Aug 27 |
Tyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
| Aug 15 |
Tyra Biosciences a new overweight at Piper Sandler as 'next gen FGFR company'
|
| Aug 8 |
Tyra Biosciences GAAP EPS of -$0.32
|
